-+ 0.00%
-+ 0.00%
-+ 0.00%
Why Celestica Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Share
Listen to the news

Shares of Celestica Inc (NYSE:CLS) rose sharply in pre-market trading after the company posted better-than-expected third-quarter fiscal 2026 results and raised its full-year guidance.

Celestica reported quarterly earnings of $3.30 per share, which beat the Street estimate of $2.99 per share. Quarterly revenue clocked in at $5.83 billion, which beat the consensus estimate of $5.48 billion.

Celestica shares jumped 16.4% to $287.00 in pre-market trading

Here are some other stocks moving in pre-market trading.

Gainers

  • 22nd Century Group Inc (NASDAQ:XXII) gained 69.8% to $0.15 in pre-market trading after the company announced an expansion of its Pinnacle Pure cigarette lineup with the addition of 100’s and menthol varieties.
  • Braiin Ltd (NASDAQ:BRAI) gained 36.8% to $2.90 in pre-market trading. Braiin shares fell 40% on Monday after the company launched Force AI, expanding the capabilities of its RADIUS AI-powered contact center platform.
  • Senti Biosciences Holdings Inc (NASDAQ:SNTI) gained 29.6% to $0.23 in pre-market trading after the company announced it received stockholders’ approval for its merger with ST NewCo.
  • Dreamland Ltd (NASDAQ:TDIC) jumped 18.1% to $1.77 in pre-market trading after declining 3% on Monday.
  • Ainos Inc (NASDAQ:AIMD) rose 16.2% to $0.91 in pre-market trading after declining over 6% on Monday.
  • Quantum Cyber NV (NASDAQ:QUCY) gained 13.8% to $0.97 in pre-market trading after dipping over 15% on Monday.
  • PowerBank Corporation (NASDAQ:PBK) gained 13.1% to $0.1604 in pre-market trading. PowerBank filed prospectus to offer up to $200 million of securities.
  • IGC Pharma Inc (NYSE:IGC) climbed 12% to $0.28 in pre-market trading.
  • Trugolf Holdings Inc (NASDAQ:TRUG) rose 10.2% to $0.95 in pre-market trading.

Losers

  • Datavault AI Inc (NASDAQ:DVLT) gained 37.4% to $0.083 in pre-market trading after the company announced its previously issued financial statements for Q3 2025 through Q2 2026 should no longer be relied upon. Restatements are expected to reduce the company’s total assets.
  • SciSparc Ltd. (NASDAQ:SPRC) fell 35.7% to $0.8295 in pre-market trading. The company reduced its warrant exercise price to $1 per share in its inducement agreement.
  • Onconetix, Inc. (NASDAQ:ONCO) fell 19.6% to $0.3208 in pre-market trading after announcing a 1-for-10 reverse stock split.
  • RedCloud Holdings plc (NASDAQ:RCT) fell 17.9% to $0.0679 in pre-market trading after gaining around 9% on Monday. RedCloud repaid all convertible notes in full.
  • Azitra, Inc. (NYSE:AZTR) fell 13.7% to $1.30 in pre-market trading after gaining 114% on Monday.
  • Green Circle Decarbonize Techno (NASDAQ:GCDT) fell 12.4% to $0.1353 in pre-market trading after dipping 12% on Monday. Green Circle Decarbonize Technology announced that it is not aware of any material undisclosed developments regarding its operations.
  • Haoxi Health Technology Limited (NASDAQ:HAO) tumbled 11.7% to $1.73 in pre-market trading after falling 5% on Monday.
  • Stratum Holdings Corp. (NASDAQ:SRTM) fell 11.1% to $0.2668 in pre-market trading after tumbling 30% on Monday. The company and Ocean Power announced a non-binding LOI for a proposed collaboration to demonstrate offshore data center assets powered by renewable wave, wind, and solar energy.
  • Valion Bio, Inc. (NASDAQ:VBIO) declined 9.9% to $0.7570 in pre-market trading after tumbling over 10% on Monday. The company announced that it has received unsolicited acquisition inquiries from independent third parties concerning its wholly owned contract development and manufacturing organization, Velocity Bioworks.
  • CBAK Energy Technology Ltd (NASDAQ:CBAT) fell 7.8% to $0.77 in pre-market trading.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending